Common #Diabetes #Meds Linked to Serious Complication Risk by Serena Gordon | #CornerInsure #Health | Since diabetes is an ongoing problem for many of us in retirement, I decided that this was a good article to share with our followers. –Dave Obregon
People taking a class of diabetes medications called SGLT2s have up to three times the risk for a serious complication called diabetic ketoacidosis (DKA) compared to people taking another drug, new research reveals.
SGLT2 (sodium-glucose cotransporter-2) inhibitors — such as Farxiga, Jardiance and Invokana — are a newer type of oral diabetes medicine. This class of medications is known to have many positive effects, including lowering a patient’s risk of heart attack, heart failure, kidney disease and death from heart disease.
But several troubling side effects, including infections and a possible increased risk of DKA, have emerged.
To read the remainder of this insightful article, click here!